|
|
|
Volumn 54, Issue 2, 1999, Pages 79-86
|
|
New findings in migraine therapy;Traitements antimigraineux: Present et avenir
|
|
Author keywords
Acute treatment; Migraine; Prophylaxis; Riboflavin; Triptans
|
|
Indexed keywords
ALMOTRIPTAN;
ALNIDITAN;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CYCLANDELATE;
DIHYDROERGOTAMINE;
ELETRIPTAN;
FLUNARIZINE;
FROVATRIPTAN;
IBUPROFEN;
KETOPROFEN;
LAMOTRIGINE;
LIDOCAINE;
LYSINE ACETYLSALICYLATE;
MAGNESIUM;
METOCLOPRAMIDE;
NARATRIPTAN;
NONSTEROID ANTIINFLAMMATORY AGENT;
PIZOTIFEN;
PLACEBO;
RIBOFLAVIN;
RIZATRIPTAN;
ROFENID;
SUMATRIPTAN SUCCINATE;
UNCLASSIFIED DRUG;
VALPROIC ACID;
VIGABATRIN;
ZOLMITRIPTAN;
SEROTONIN AGONIST;
SEROTONIN RECEPTOR;
SUMATRIPTAN;
ANALGESIC ACTIVITY;
DRUG BIOAVAILABILITY;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG PENETRATION;
DRUG RECEPTOR BINDING;
DRUG SAFETY;
HUMAN;
HYDROPHILICITY;
INTRANASAL DRUG ADMINISTRATION;
MIGRAINE;
NEUROTOXICITY;
ORAL DRUG ADMINISTRATION;
REVIEW;
SUBCUTANEOUS DRUG ADMINISTRATION;
TREATMENT PLANNING;
DRUG EFFECT;
FORECASTING;
TIME;
ADMINISTRATION, ORAL;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
FORECASTING;
HUMANS;
INJECTIONS, SUBCUTANEOUS;
MIGRAINE DISORDERS;
PLACEBOS;
RECEPTORS, SEROTONIN;
RIBOFLAVIN;
SEROTONIN AGONISTS;
SUMATRIPTAN;
TIME FACTORS;
|
|
EID: 0033073148
PISSN: 00353663
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (3)
|
|
References (52)
|
